- Home
- KFFB vs MCRB Comparison
KFFB vs MCRB Comparison
Compare KFFB & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KFFB | MCRB |
|---|---|---|
| Founded | 2005 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4M | 47.4M |
| IPO Year | 2004 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KFFB | MCRB |
|---|---|---|
| Price | $5.66 | $5.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 5.6K | ★ 51.0K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.52 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $15,000.00 | ★ $789,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $37.80 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.01 | $4.32 |
| 52 Week High | $6.45 | $29.98 |
Technical Indicators
Market Signals| Indicator | KFFB | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 56.29 | 48.54 |
| Support Level | $4.33 | $4.45 |
| Resistance Level | $6.45 | $5.65 |
| Average True Range (ATR) | 0.36 | 0.33 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 56.15 | 43.21 |
Price Performance
Historical ComparisonAbout KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.